Home > News > American Bio Medica and Nanogen Sign Supply Agreement
August 23rd, 2006
American Bio Medica and Nanogen Sign Supply Agreement
Abstract:
American Bio Medica Corporation (NASDAQ: ABMC), a global provider of immunoassay diagnostic test kits, and Nanogen, Inc. (NASDAQ: NGEN), a developer of advanced diagnostic products, announced today that they have entered into a supply agreement in which ABMC will sell its rapid drugs of abuse (DOA) tests to Nanogen.
Source:
businesswire
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Announcements
NRL charters Navy’s quantum inertial navigation path to reduce drift April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||